# NCT01013649 (NCT01013649)

> Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01013649
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: National Cancer Institute (NCI)
- Conditions: Pancreatic Adenocarcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Intraductal Papillary-Mucinous Neoplasm; Stage I Pancreatic Cancer AJCC v6 and v7; Stage II Pancreatic Cancer AJCC v6 and v7
- Interventions: 3-Dimensional Conformal Radiation Therapy; Biospecimen Collection; Capecitabine; Chemotherapy; Computed Tomography; Erlotinib Hydrochloride; Fluorouracil; Gemcitabine Hydrochloride; Intensity-Modulated Radiation Therapy; Magnetic Resonance Imaging; Quality-of-Life Assessment; X-Ray Imaging
- Enrollment: 546
- Primary outcome: Overall Survival (Percentage of Participants Alive) [Phase II]
- Primary outcome: Overall Survival (Percentage of Participants Alive) [Phase III]

## Commentary we found

- X threads: 39
- YouTube: 3
- Podcasts: 3
- X videos: 2

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nct01013649

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01013649", "email": "<work email>"}; the inbox owner confirms by the emailed link.